Literature DB >> 11037365

Characterising psychosis in the Australian National Survey of Mental Health and Wellbeing Study on Low Prevalence (psychotic) Disorders.

S Rosenman1, A Korten, J Medway, M Evans.   

Abstract

OBJECTIVE: This study examines the factorial structure of symptoms and signs in psychosis in data from the Study on Low Prevalence (psychotic) Disorders which is part of the National Survey of Mental Health and Wellbeing, Australia 1997-1998.
METHOD: The present study examined a wide variety of symptoms taken from the Schedules for Clinical Assessment in Neuropsychiatry items and the substance use items in the Diagnostic Interview for Psychosis, an instrument specially constructed for the national study. The instrument was applied to 980 community and hospital subjects with a wide range of psychotic illness diagnoses. The data were factor analysed and scales of 'domains of psychopathology' derived.
RESULTS: The data were best fitted by five principal factors ('domains') which can be approximately labelled dysphoria, positive symptoms, substance use, mania and negative symptoms/incoherence. These factors together explained 55.4% of variance in symptoms. Solutions with more numerous factors did not improve the representation.
CONCLUSION: The five domains successfully characterise a large part of the variance in psychopathology found in the present study of low prevalence (psychotic) disorders. The approach allows sufferer's symptom range and severity to be well expressed without multiple comorbid diagnoses or the limits imposed by categorical diagnosis. Knowledge of alternative dimensional representations of psychopathology may usefully complement our use of categories, enhance awareness of symptoms and ensure that important psychopathology is heeded in practice and research.

Entities:  

Mesh:

Year:  2000        PMID: 11037365     DOI: 10.1080/j.1440-1614.2000.00824.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  8 in total

Review 1.  Categorical vs dimensional classifications of psychotic disorders.

Authors:  Melissa Potuzak; Caitlin Ravichandran; Kathryn E Lewandowski; Dost Ongür; Bruce M Cohen
Journal:  Compr Psychiatry       Date:  2012-06-07       Impact factor: 3.735

2.  [Psychometric properties of dimensional measures derived from the latest German version of the Schedules for Clinical Assessment in Neuropsychiatry 2.1].

Authors:  M Schützwohl; T Kallert; L Jurjanz
Journal:  Nervenarzt       Date:  2007-03       Impact factor: 1.214

3.  Kraepelin was right: a latent class analysis of symptom dimensions in patients and controls.

Authors:  Eske M Derks; Judith Allardyce; Marco P Boks; Jeroen K Vermunt; Ron Hijman; Roel A Ophoff
Journal:  Schizophr Bull       Date:  2010-09-23       Impact factor: 9.306

Review 4.  Substance use disorder and schizophrenia: prevalence and sociodemographic characteristics in the Latin American population.

Authors:  Lorena Jiménez-Castro; Henriette Raventós-Vorst; Michael Escamilla
Journal:  Actas Esp Psiquiatr       Date:  2011-03-01       Impact factor: 1.196

5.  Substance use disorder comorbidity with schizophrenia in families of Mexican and Central American ancestry.

Authors:  Lorena Jiménez-Castro; Elizabeth Hare; Rolando Medina; Henriette Raventos; Humberto Nicolini; Ricardo Mendoza; Alfonso Ontiveros; Alvaro Jerez; Rodrigo Muñoz; Albana Dassori; Michael Escamilla
Journal:  Schizophr Res       Date:  2010-03-19       Impact factor: 4.939

6.  Harnessing clinical psychiatric data with an electronic assessment tool (OPCRIT+): the utility of symptom dimensions.

Authors:  Philip James Brittain; Sarah Elizabeth Margaret Lobo; James Rucker; Myanthi Amarasinghe; Anantha Padmanabha Pillai Anilkumar; Martin Baggaley; Pallavi Banerjee; Jenny Bearn; Matthew Broadbent; Matthew Butler; Colin Donald Campbell; Anthony James Cleare; Luiz Dratcu; Sophia Frangou; Fiona Gaughran; Matthew Goldin; Annika Henke; Nikola Kern; Abdallah Krayem; Faiza Mufti; Ronan McIvor; Humphrey Needham-Bennett; Stuart Newman; Dele Olajide; David O'Flynn; Ranga Rao; Ijaz Ur Rehman; Gertrude Seneviratne; Daniel Stahl; Sajid Suleman; Janet Treasure; John Tully; David Veale; Robert Stewart; Peter McGuffin; Simon Lovestone; Matthew Hotopf; Gunter Schumann
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

7.  Prognostic Value of Affective Symptoms in First-Admission Psychotic Patients.

Authors:  Marta Arrasate; Itxaso González-Ortega; Adriana García-Alocén; Susana Alberich; Iñaki Zorrilla; Ana González-Pinto
Journal:  Int J Mol Sci       Date:  2016-06-30       Impact factor: 5.923

8.  Schizophrenia and Suicide Attempts: Findings from a Representative Community-Based Canadian Sample.

Authors:  Esme Fuller-Thomson; Bailey Hollister
Journal:  Schizophr Res Treatment       Date:  2016-02-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.